In conclusion, AR knockdown results in the inactivation of the ERK/ELK‐1 signalling pathway that, in turn, leads to the downregulation of FEN1 and improves the DTX sensitivity of prostate cancer cells (Figure. 8). This evidence concerns the gene FEN1 and prostate cancer.